UNC Lineberger Comprehensive Cancer Center members will take a leading role at the 2013 San Antonio Breast Cancer Symposium this week, speaking on topics ranging from systemic therapies for breast cancer patients to how early-career scientists can balance research with clinical practice. The symposium, held Dec. 10-14 in San Antonio, Texas, provides an opportunity for the world’s leading physicians and researchers to exchange ideas and learn about advances in understanding and treating breast cancer.
Charles Perou, PhD, May Goldman Shaw Distinguished Professor of Molecular Oncology and Professor of Genetics, and Pathology and Laboratory Medicine, will deliver one of the capstone Year in Review presentations, providing an overview of the year’s translational research highlights. Dr. Perou’s advances in understanding the genomics of breast cancer have revised the clinical understanding of the disease and led the way for the development of the PAM50 clinical test for breast cancer risk approved for use by the FDA this year.
Lisa Carey, MD, Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, will participate in a panel on “Balancing Research and Clinical Practice” and discuss management of triple negative metastatic breast cancer as part of a session on “Metastatic Breast Cancer: An Update on Management and Supportive Care.” Dr. Carey conducts extensive research into the subtypes of breast cancer and the effectiveness of chemotherapy while also seeing patients in her roles as the Medical Director of the UNC Breast Center, the Chief of Hematology/Oncology, and the Physician-in-Chief of the UNC North Carolina Cancer Hospital.
Physician/Researcher Carey Anders, MD, Assistant Professor in the UNC School of Medicine, will present on “Breast Cancer in 2013: An Overview of Systemic and Local Therapies” and deliver a talk on “How to Get the Most Out of Your Fellowship Years.” Dr. Anders treats patients and researches treatments for brain metastases linked to breast cancer as part of her work with the UNC Breast Center.
Hyman B. Muss, MD, Professor in the UNC School of Medicine, will deliver the lecture “Adjuvant Chemotherapy in the Elderly: Making the Right Decision.” The leader of UNC Lineberger’s Geriatric Oncology Program, Dr. Muss is one of the world’s leading clinicians and researchers in treating cancer in elderly patients.
The annual San Antonio symposium provides physicians and researchers a platform to share state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease with an international audience of academic and private physicians and researchers.